Everything that moves a molecule's value is public. None of it is in one place.
Now it is.
Patent and exclusivity dates, trial completions, FDA action dates, and the federal funding and procurement that name the molecule, matched and dated on one runway, so you know what is expiring, what is moving, and who is paying.
Six molecules. One line of time.
Patents from the register edition, exclusivity with its expiry, generic entry windows, trial completions, action dates, and the public notices that name the class. Today is the teal line. Everything to its right is dated in a public record.
An action becomes a chain.
A regulatory action is the start of a sequence the record already contains: the label, the register, the notices that follow, the awards that name the class. The module reads the chain with the lag observed at each step.
Two measures. Never one number.
A molecule's government exposure and a sponsor's receipts are different claims with different bases. The module reports both, labels which is which, and never adds them.
Every link says what kind of claim it is.
Most graph products draw a line between two things and leave you to guess what it means. Life Science Intelligence draws three kinds of line, and money only travels along one of them. A sponsor's receipts and a molecule's mentions are never added together, and a tagged association is never mistaken for attribution.
Objects left. Links center. Evidence right.
Select any object and the picture redraws around it with the edge grammar visible. The dossier on the right serves the exclusivity runway, government exposure with the funder and buyer split, safety actions, and the provenance footer. Click a node to walk, double-click to expand.
Exclusivity runway
Government exposure
Safety actions
lexicon v3 · pick rule v4 · register edition 2026-08
reject and quarantine rows excluded · figures carry n
Build the case by dragging. Every card fills itself from the record.
Drop a molecule, a sponsor, an agency, or a trial set onto the board. The card fills itself from the record and the ties draw between anything already linked, each tie labeled with its figure, its basis, and its n. Suggested links arrive as ghost cards you keep or dismiss. Name the board, save it, share it with an expiry, or open it as a free canvas.
One molecule, fully unpacked.
The dossier is the evidence behind every card. Runway dates from the register edition, referencing awards by agency, active trials with sponsors, the action history, safety actions where they exist, and the seven-layer ledger at the foot of the page.
| Trial | Phase | Sponsor | Enrolled | Primary completion |
|---|---|---|---|---|
| Long-acting regimen, treatment-naive adults | 3 | Sponsor parent A | 1,240 | Mar 2027 |
| Switch study, virologically suppressed | 3 | Sponsor parent A | 860 | Jun 2027 |
| Pediatric dosing, 12 to 18 | 2 | Academic network | 214 | Nov 2026 |
| Pre-exposure, quarterly injection | 3 | Federal institute | 3,300 | Sep 2027 |
Four capabilities ride the module.
The existing FDA capabilities read from the same objects and links, so an approval cascade, a trial trajectory, a generic entry, or a safety action can be pinned to a board like any other object.
Seven layers on every figure.
Nothing on a runway, a board, or a memo is computed on the fly from a model. It is served from the record, with its basis and its n.
The same workbench, other domains.
Each module binds its own objects and link rules to the same investigation surface. Pin, link, board, memo: the grammar carries across.
Bring a molecule. Leave with the runway.
A 30-minute walkthrough on your own molecules and markets. Enterprise access includes the module, the board, and the memo export.